1. Home
  2. ELTX vs FJET Comparison

ELTX vs FJET Comparison

Compare ELTX & FJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.52

Market Cap

45.6M

Sector

Health Care

ML Signal

N/A

Logo Starfighters Space Inc. Common Stock

FJET

Starfighters Space Inc. Common Stock

N/A

Current Price

$0.94

Market Cap

48.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
FJET
Founded
2011
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
48.7M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
ELTX
FJET
Price
$1.52
$0.94
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $13.00
N/A
AVG Volume (30 Days)
305.0K
★ 1.3M
Earning Date
11-05-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
N/A
EPS
N/A
★ N/A
Revenue
★ $2,301,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.25
$0.67
52 Week High
$16.00
$28.56

Technical Indicators

Market Signals
Indicator
ELTX
FJET
Relative Strength Index (RSI) 40.97 39.99
Support Level $1.35 $0.70
Resistance Level $1.98 $0.96
Average True Range (ATR) 0.19 0.13
MACD 0.01 0.06
Stochastic Oscillator 42.19 46.39

Price Performance

Historical Comparison
ELTX
FJET

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About FJET Starfighters Space Inc. Common Stock

Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida, with an additional base of operations at Midland International Air & Space Port in Texas, and has a fleet of seven F-104 Fighter jets that are capable of flying MACH 2+. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company has one operating segment, which is principally the operations of F-104 Fighter jets and the development of infrastructure for orbital space launch.

Share on Social Networks: